Aqemia, a French startup that’s meshing “quantum-inspired physics” with machine learning to find new drugs, has raised $38 million in a fresh round of funding led by San Francisco-based VC firm Cathay Innovation. This is Aqemia’s second fundraise of the year — it announced a €30 million ($31.5 million) raise back in January — and it takes the company’s total funding raised past the $100 million mark. Founded in Paris by Maximilien Levesque and Emmanuelle Rolland-Martiano (pictured above) in 2019...